AZ and BMS combine to develop new diabetes drugs
January 19, 2007Sales and Marketing
AstraZeneca and Bristol-Myers-Squibb are collaborating on the development of two new drugs for the treatment of type II diabetes.Saxagliptin, a …
World’s first stem cell trial for stroke likely to get green light
January 19, 2007Research and Development ReNeuron, stem cell, stroke
A cutting-edge stem cell clinical trial for chronic stroke patients looks set to go ahead later this year.Biotech company ReNeuron, …
New software to cut unnecessary hospital stays
January 19, 2007Clinicians are being urged to use new software developed to help the NHS prevent unnecessary admission to hospital.Thousands of patients …
Are you in control of your new products?
January 19, 2007Research and Development academia, innovation
The quest to convert inventions (i.e. promising ideas) into innovations (i.e. commercial products) is a central and vital feature of …
Novartis plans eight launches for 2007
January 18, 2007Sales and Marketing
Novartis is preparing to set a new record for the pharmaceutical industry by launching eight new products in the next …
Future of Alzheimer’s drugs lies with the High Court
January 9, 2007Sales and Marketing
Eisai has applied to the High Court for permission to request a legal hearing into NICE's decision to ban anti-dementia …
UK pharma is going green
January 8, 2007Sales and Marketing
With 2007 predicted to be the warmest year on record, the pressure is on for companies worldwide to 'go green'. …
Europe’s biotech sector to flourish in 2007
January 8, 2007Research and Development Europe
Analysts are predicting that 2007 will be a strong year for European biotech, which is forecast to outstrip the growth …
New class of anti-angiogenesis agents gets 2 million euro boost
January 8, 2007Research and Development
Two European biotech companies have received a grant of two million euros to jointly develop a new class of anti-angiogenesis …
Roche targets new central nervous system drugs
January 5, 2007Research and Development
Swiss-based Roche has forged a partnership that could lead to the development of new treatments for schizophrenia, cognitive disorders, Parkinson's …
GSK buys Praecis Pharmaceuticals for $59 million
January 4, 2007Research and Development, Sales and Marketing
GlaxoSmithKline has bought US-based biotech company, Praecis, to further boost its novel cancer pipeline.Its acquisition of Praecis Pharmaceuticals follows the …
Diabetic kidney disease drug hits safety obstacle
January 4, 2007Research and Development, Sales and Marketing
Swiss-based biotech company Speedel has axed its current phase III trial of SPP301 in diabetic kidney disease because of patient …
Positive EU opinion for pancreatic cancer drug Tarceva
January 3, 2007Sales and Marketing
Roche and Genentech's Tarceva has received a positive EU opinion for the treatment of metastatic pancreatic cancer and approval is …
Hants NHS hospital becomes first to be run by private sector
January 3, 2007Lymington New Forest Hospital has become the first NHS facility in England to be run entirely by the private sector.Colchester-based …
Are you reaching your customers?
January 3, 2007Sales and Marketing NHS, healthcare, market access, marketing, strategy
The NHS is changing, and it's doing so at a rate faster than at any time in its history. Huge …
Pharma failing to address MRSA drugs market
January 2, 2007Research and Development, Sales and Marketing
News that a new strain of the MRSA bug has reached Europe from the US has left drug developers under …
New consultancy to address pharma’s NHS funding challenge
January 2, 2007Sales and Marketing
A new consultancy has been launched by a team of pharma and NHS veterans to help companies bring new products …
Pfizer launches online pipeline tracker
December 21, 2006Sales and Marketing
Pfizer has launched a new online service which provides detailed insight into its R&D pipeline.The company is taking a lead …
Government accused of ‘fiddling the books’
December 21, 2006A leading GP has accused the government of fiddling the books on the uptake of practice-based commissioning.Dr David Jenner, the …
Novartis enters late-stage trials for new hepatitis C drug
December 21, 2006Research and Development, Sales and Marketing
Novartis, in collaboration with a US biotech company, has initiated phase III trials of a chronic hepatitis C drug that …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
